← Leaderboards
Sandra Palleja
Ppd Development Lp
$722,028
Attributed
$722,028
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $183.4K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$722,028 · 1
By mechanism
N01$722,028 · 1
Top collaborators
No co-investigators on record.
Most similar at Ppd Development Lp
Same institution · by research overlap
- Mary Glessner$105,093,133
- Kimberly Smith$122,921,392
- Michelle Vargas$176,419,297
- Charity-Anne Schuller$22,069,318
- Bambra Strokes$526,656,217
Others in their field
Other Rising Stars on “Clinical Trial Implementation”
- Thierry Diagana · University Of Texas Med Br Galveston$37,506,320
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Jennifer Lee O'Brien · University Of South Florida$10,506,386
- Songthip T. Ounpraseuth · Univ Of Arkansas For Med Scis$10,363,762
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- Yan Ji · Healthpartners Institute$5,300,768
Research focus
Clinical Trial ImplementationClinical TrialsClinical Trials UnitCommunicable DiseasesEarly Phase Clinical TrialInvestigationNational Institute Of Allergy And Infectious DiseaseNew AgentsPrevention
Grant awards (4)
Task A: Early Phase Clinical Trial Units (EPCTU)$183,411
N01 · FY2025 · AI · contact PI
Task A: Early Phase Clinical Trial Units (EPCTU)$182,396
N01 · FY2024 · AI · contact PI
Early Phase Clinical Trial Unit$179,268
N01 · FY2023 · AI · contact PI
Early Phase Clinical Trial Unit$176,953
N01 · FY2022 · AI · contact PI